Ahn, J., Lo, M., Yan, L., Damon, L., Dunavin, N., Ferng, T., Gaensler, K., Lee, J., Othman, T., Sayre, P., Smith, C., Olin, R., Logan, A. (2025). Treatment of newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia using hypercvad with ponatinib is associated with excellent survival with selective use of blinatumomab and allogeneic hematopoietic cell transplantation. Blood. https://doi.org/10.1182/blood-2025-3346